Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Man with telescope looking at 2023

Portfolio > Economy & Markets > Stocks

5 Battered Stocks to Watch in 2023

Your article was successfully shared with the contacts you provided.

U.S. companies had a lot to overcome in the latter half of 2022 with rising interest rates, more budget-conscious consumers and a sagging stock market. That’s left some of them in very tough spots at the start of the new year.

These five should be watched closely:

The Carnival Valor cruise ship sets sail from the Port of New Orleans. The Carnival Valor cruise ship sets sail from the Port of New Orleans. (Photo: Bloomberg)


Carnival Corp. entered 2020 with a full head of steam, having reported record sales and profit the year before. Three years into the pandemic, it’s a different company.

The cruise line giant, like other ship operators, shut down for more than a year due to Covid. It sold new shares and borrowed heavily, tripling its long-term debt to $32 billion over the past three years. Rising interest rates will make that sum even tougher to pay down.

Carnival's Rising Debt Burden | Cruise operator took on loans to survive pandemic

Meanwhile, Carnival’s fleet has shrunk by 11% as older and less fuel-efficient ships were sold or retired. Passenger capacity is about the same, as newly added ships are larger. The challenge for new Chief Executive Officer Josh Weinstein, who took over in August, will be filling the remaining vessels at prices that allow the company to return to profitability.

That’s been difficult in the wake of weakening economies in Europe and Covid outbreaks in China. The company said last week that Europe and Asia bookings for 2023 have trailed pre-pandemic levels, while North America and Australia are tracking ahead.

Weinstein hopes to entice people back to cruising next year with a significant step in advertising, and he’s working with each of Carnival’s brands to hone their position in the marketplace. On a recent earnings call he likened the company’s relaunch over the last 18 months to being “the world’s largest startup.”

Carnival shares trade as if more trouble lies ahead. The stock is down more than 80% since December 2019 — the worst performer among the three big cruise companies — and recently touched a 30-year bottom.  “At the end of the day, we think expectations are low,” said Credit Suisse Securities analyst Benjamin Chaiken.

Beyond Meat

It’s also been a rough year for Beyond Meat Inc. Sales of fake meat have fallen at grocery stores and product tests with fast-food partners didn’t result in any Beyond products becoming permanent menu items in the US.

Two separate rounds of layoffs eliminated more than 20% of employees, or about 240 roles.

Beyond Meat Has Fallen 95% From Peak | Stock has been on steady slide for more than a year

The company also endured its share of scandals — ranging from its chief operating officer being arrested in an alleged road-rage incident after a football game to a plant in Pennsylvania being linked to Listeria contamination and other safety issues. The COO, finance chief, head of supply chain and chief growth officer have all departed in recent months.

Beyond Meat says it will finally be cash-flow positive in the second half of 2023, but analysts are skeptical that can happen until sales stabilize. Quarterly spending has come down but the company had just $390 million in cash on hand at the end of the third quarter and more than $1 billion in debt.

CEO Ethan Brown maintains that plant-based meat will eventually replace the real thing. Investors are far from convinced; the stock has fallen about 95% from its peak in 2019 and short interest accounts for around 40% of the available shares. It’s unclear how long Brown — or his company — will survive without a meaningful turnaround.


March could offer a tell-tale moment for debt-strapped online used-car retailer Carvana Co.

That’s when when an interest payment is due on its 2029 bonds. If the company makes the payment, it could be a sign that it has a plan to restructure debt with creditors and carry on. If not, then bankruptcy “has to clearly be thought of as a possible outcome,” according to Bloomberg Intelligence analyst Joel Levington.

Carvana is in a real bind. The company aggressively bought used-car inventory when demand was high and sticker prices were soaring early in the year, relying on credit agreements and share sales to raise cash.

Then prices tumbled as automakers found more semiconductors and boosted new-vehicle production, shifting buyers’ focus. The once-hot used-car market sank even more as inflation and rising interest rates made purchases less affordable for lower-income consumers.

In the past 12 months, used-vehicle prices have tumbled 14%, according to Manheim, the nation’s largest wholesale car auction. Manheim owner Cox Automotive expects pre-owned sales and prices to fall even more in 2023.

A Carvana vending machine location in Novi, Michigan. (Photo: Bloomberg) A Carvana vending machine location in Novi, Michigan. (Photo: Bloomberg)

After earnings from larger rival CarMax Inc. came in well below expectations last week, Levington suggested Carvana may be facing a “devastating setback for its turnaround plans.”

The company’s largest creditors have agreed to jointly work to get a deal with management to refinance its debt. Carvana bonds have traded below 50 cents on the dollar, indicating a high chance of default.

Verve Therapeutics

Next year will be crucial for Verve Therapeutics Inc., a biotech company developing a gene-editing treatment for heart disease.

Verve wants to edit human DNA to reduce the risk of heart attack, an idea that captivated investors when the company went public in mid-2021. The plan is to first focus on people with an inherited form of high cholesterol, which affects 31 million people globally, before expanding to broader uses.

But the regulatory path is turning out to be much tougher than previously thought.

An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. lab in Foster City, California, U.S. Photographer: David Paul Morris/Bloomberg An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. lab in Foster City, California, U.S. (Photo: David Paul Morris/Bloomberg)

The U.S. Food and Drug Administration in November halted studies of the company’s lead drug in order to get more information about potency, unintended changes in DNA and the risk that those alterations could be passed down to offspring. While Verve works to answer those questions and get back on track, the stock price has plummeted amid mounting uncertainty.

Clinical trials are still moving forward overseas, and Verve plans to share data from them next year. That should give investors a better sense of how well the drug might work and how safe it could be.

But even if everything looks good, Verve will still need years yet to prove the drug’s promise — and assure investors there’s enough appetite for it. The company says it has enough cash to last through 2025.

Electric Vehicle Start-Ups

Electric-vehicle startups raised more than $10 billion in 2020 and 2021 by capitalizing on the fad of going public through mergers with special purpose acquisition companies, or SPACs.

Despite that influx of cash, many companies struggled to stay afloat in 2022 after running into the hard reality of just how much money is required to put a car on the road. Rising interest rates and less-friendly capital markets haven’t helped.

In June, Electric Last Mile Solutions Inc. became the first of the EV startups to go out of business, liquidating its assets through a Chapter 7 bankruptcy process. Chinese startup Niutron folded earlier this month without delivering a single car to the approximately 24,000 customers who had paid deposits.

Cash Raised in EV SPAC Mergers | (USD in Billions) in a Bloomberg Chart

It looks increasingly possible that the trend will continue. Canoo Inc. and Faraday Future Intelligent Electric Inc. have already warned about their cash balances, and it will be difficult for them to raise the hundreds of millions of dollars required to ramp up volume.

Even companies that are more flush, such as Saudi-controlled Lucid Group Inc., have scaled back their output goals amid supply-chain and production hurdles.

With funding options scarce, some EV startups may look to consolidation as a means of survival. As Tesla Inc. CEO Elon Musk noted earlier this year, starting a car company “is mega pain.”

–With assistance from Christopher Palmeri, Deena Shanker, David Welch, Angelica Peebles and Sean O’Kane.

(Image: Chris Nicholls)

Copyright 2022 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.